Abionyx Pharma (CHIX:ABNXP) FFO


CHIX:ABNXP Abionyx Pharma CHIX:ABNXP
15 GF Score
Price €1.73
GF Value €0.70
! 4 Warning Signs
View Full Analysis

What is Abionyx Pharma FFO?

FFO (Funds from operations) only applies to REITs.

CHIX:ABNXP
15GF Score
Abionyx Pharma CHIX:ABNXP
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Abionyx Pharma (CHIX:ABNXP) Overvalued in 2026?

Based on GuruFocus' analysis, Abionyx Pharma stock appears to be overvalued. The current stock price of €1.73 is trading 147.4% above its estimated GF Value™ of €0.70.

Key valuation signals for CHIX:ABNXP:

  • FFO:
  • GF Value™: €0.70 vs. price of €1.73 (147.4% above fair value)
  • GF Score™: 15/100 with 4 warning signs

No single metric tells the full story. See the CHIX:ABNXP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abionyx Pharma Business Description

Address 33-43 Avenue Georges Pompidou-Bat D2, Balma, FRA, 31130
Abionyx Pharma is a new generation biotech company dedicated to the discovery and development of innovative therapies for patients without existing or effective treatment. The biotech assets inherited from CERENIS Therapeutics constitute a portfolio of valuable programs for the treatment of cardiovascular diseases and associated metabolic diseases such as NAFLD and NASH as well as an HDL targeted drug delivery platform in oncology, more specifically in Immuno oncology and chemotherapy.
15GF Score

Get the complete analysis for CHIX:ABNXP

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.73
Price
€0.70
GF Value